Earnings call transcript: American Vanguard Q1 2025 sees stock dip amid lower sales

American Vanguard (AVD) reported a 14% year-over-year decline in Q1 2025 net sales, falling to $116 million, with adjusted EBITDA dropping to $3 million from $15.5 million, leading to a 9.67% stock price decrease. The company revised its full-year adjusted EBITDA guidance downward to $40-44 million, citing continued destocking by customers and competitive pricing pressures, despite reducing debt by 14% and expecting a stronger second half. While InvestingPro analysts maintain a bullish outlook, the company faces challenges including supply chain disruptions and internal control issues, however, executives expressed optimism about a potential market recovery and the company's transformation initiatives.

Analysis

American Vanguard Corporation (AVD) reported a challenging first quarter for 2025, with net sales declining 14% year-over-year to $116 million and adjusted EBITDA plummeting to $3 million from $15.5 million in the prior year, triggering a 9.67% drop in its stock price during regular trading. These results were attributed to persistent customer destocking, the $6 million top-line impact from the removal of its Dactol product, weakness in the Mexican agave market, drought conditions in Australia, and competitive pricing pressures which also compressed gross profit margins to 26% from 31%. Despite these headwinds, AVD demonstrated operational discipline by reducing operating expenses by $5 million and improving net working capital by $86 million, alongside a 14% reduction in debt. However, the company lowered its full-year 2025 adjusted EBITDA guidance to $40-44 million from a previous $45-52 million, and revenue estimates to $535-545 million. Management anticipates a stronger second half of 2025, citing historically low channel inventories, early signs of customer restocking, and projected record corn acreage, which benefits AVD's product portfolio. The company is also pursuing transformation initiatives aimed at long-term cost structure improvements and a 15% adjusted EBITDA margin, though it faces ongoing risks including the need to address internal control weaknesses in its Australian subsidiary and refinance its credit agreement by Q3 2026, likely at higher interest rates. Despite the current difficulties and a 'moderately negative' sentiment signal, InvestingPro analysts maintain a bullish outlook and AVD has continued its 29-year streak of dividend payments, currently yielding 2.47%.

Key Decisions for Investors

• Investors should exercise caution regarding American Vanguard in the near term, acknowledging the significant Q1 2025 earnings miss, downward revision of full-year guidance, and the resultant negative stock performance driven by ongoing market and company-specific headwinds.
• Monitor for key inflection points such as a sustained reversal in customer destocking patterns, tangible progress on the company's transformation initiatives including cost reduction and working capital efficiency, and improvements in gross and adjusted EBITDA margins, which could signal a turnaround.
• Closely track developments related to the upcoming credit agreement refinancing, the resolution of internal control issues, the competitive pricing environment, and potential tariff impacts, as these factors will be critical to AVD's future financial health and ability to achieve its long-term targets; the consistent dividend provides a modest yield but should be weighed against the operational risks and recovery timeline.